<h1 itemprop="aspect"> <strong>Kepivance Side Effects</strong></h1><h1><strong><img class="alignright  wp-image-3519" alt="Kepivance injection label" src="http://www.bad-drug.net/wp-content/uploads/2012/07/Kepivance-injection1.jpg?1df917" width="240" height="180" pagespeed_url_hash="1726721671" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/>Serious Side Effects of Kepivance</strong></h1><div><ul><li>elevated temperature or a<strong> fever</strong></li><li><strong>reactions in the mucus membrane</strong> or <strong>skin</strong>: hives, rashes, inflammation, or strange feelings in the mouth, tongue swelling or discoloration, or taste change</li><li>swelling of the hands, feet or face which may indicate<strong> proteinuria</strong> (raised amounts of protein in urine), which can be a sign of <strong>kidney disease</strong></li><li>increase of blood enzymes in the pancreas (<strong><a title="hyperlipasemia" href="http://www.chemocare.com/managing/hyperlipasemia-high-lipase.asp" target="_blank">hyperlipasemia</a></strong>)</li><li><strong>allergic reaction</strong>: tightness in chest, itchiness, rashes, swelling of the lips, mouth, face or tongue, or difficult breathing</li></ul><h2>Common Side Effects of Kepivance</h2><ul><li>pain in joints</li><li>tenderness and swelling</li><li>raised blood pressure</li><li>numbness or tingling around the mouth</li></ul></div></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Kepivance </strong></h2> In <strong>May of 2009</strong>, the FDA modified the "<strong>Precautions</strong>" section for the Kepivance label to state that Kepivance may interact with <strong>heparin</strong>. If heparin is used in your I.V.,<strong> flush the I.V. with saline</strong> to avoid any adverse reactions this combination may cause.Kepivance is listed by the U.S. Food and Drug Administration as a<strong> pregnancy Category C</strong> medication. If you are <strong>pregnant</strong>, <strong>planning on becoming pregnant,</strong> or <strong>breastfeeding</strong>, it is important to consult your doctor before using Kepivance. It is <strong>unknown</strong> if Kepivance will harm the fetus, or if Kepivance may be transferred through breastmilk. Clinical trials in animals show that when used in pregnancy, Kepivance may decrease the weight of the fetus.<strong>Before</strong> taking Kepivance let your doctor know if you are allergic to any products made with <strong>E.Coli proteins</strong>.If used for <strong>non-blood related cancers</strong>, Kepivance may <strong>increase the risk</strong> of developing a <strong>tumor</strong>.</div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Kepivance Treatment and Use </strong></h2><p><strong>Kepivanace</strong> | Palifermin is marketed by <strong>Biovitrum</strong> as a <strong>human keratinocyte growth factor (<a target="_blank" title="KGF" href="http://en.wikipedia.org/wiki/Keratinocyte_growth_factor" target="_blank">KGF</a>)</strong> generated through the joining together of two different species of DNA cells (<strong>recombinant DNA technology</strong>). Kepivance is used to treat the following conditions:</p><ul><li>Decrease the risk of ulcers or sores developing in the mouth</li><li>Reduce the occurrence of ulcers and sores in blood cancer patients who have undergone chemotherapy or radiotherapy before receiving bone marrow transplants</li><li>Side effects or <a target="_blank" title="mucositis" href="http://en.wikipedia.org/wiki/Mucositis" target="_blank">mucositis</a></li></ul><h2>How Does Kepivance Work?</h2><p><strong>Palifermin</strong>, the active ingredient in Kepivance causes the <strong>epithelial cells</strong> in the lining of the mouth and gastrointestinal tract to develop. In patients undergoing <strong>chemotherapy</strong>, these cells do not reproduce as quickly, leaving these areas <strong>susceptible to ulcers</strong> or <strong>sores</strong>. By triggering the growth of epithelial cells, Kepivance<strong> prevents and treats</strong> certain side effects of chemotherapy.</p><h2>How is Kepivance Given?</h2><p>Kepivance is an<strong> intravenous (I.V.) infusion</strong> given to patients 3 days before and 3 days after chemotherapy. Normally, a doctor or nurse administers Kepivance to patients, however, patients may be asked to use Kepivance at home, and will be given precise instructions on the preparation, dosage, use and storage of this medication.</p><p>Kepivance <strong>should not</strong> be administered to patients within<strong> 24 hours before or after</strong> chemotherapy.</p></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Kepivance</h2> <strong>Brand name</strong>:<br/><ul><br/><li>Kepivance</li><br/></ul><br/> <strong>Generic name (Unavailable)</strong>:<br/><ul><br/><li>Palifermin</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Kepivance </strong></h2>